Safety experience with bosentan in 146 children 2-11 years old with pulmonary arterial hypertension: results from the European Postmarketing Surveillance program
Published inPediatric research, vol. 64, no. 2, p. 200-204
Publication date2008
Abstract
Keywords
- Antihypertensive Agents/adverse effects/therapeutic use
- Child
- Child, Preschool
- Europe
- Female
- Humans
- Hypertension, Pulmonary/drug therapy/metabolism
- Liver
- Longitudinal Studies
- Male
- Product Surveillance, Postmarketing
- Sulfonamides/adverse effects/therapeutic use
- Transaminases/metabolism
Affiliation entities
Research groups
Citation (ISO format)
BEGHETTI, Maurice et al. Safety experience with bosentan in 146 children 2-11 years old with pulmonary arterial hypertension: results from the European Postmarketing Surveillance program. In: Pediatric research, 2008, vol. 64, n° 2, p. 200–204. doi: 10.1203/PDR.0b013e318179954c
Main files (1)
Article (Accepted version)
Identifiers
- PID : unige:1057
- DOI : 10.1203/PDR.0b013e318179954c
- PMID : 18414142
ISSN of the journal0031-3998